VIDEX EC Drug Patent Profile
✉ Email this page to a colleague
When do Videx Ec patents expire, and when can generic versions of Videx Ec launch?
Videx Ec is a drug marketed by Bristol Myers Squibb and is included in one NDA.
The generic ingredient in VIDEX EC is didanosine. There are eight drug master file entries for this compound. Additional details are available on the didanosine profile page.
Summary for VIDEX EC
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 124 |
Patent Applications: | 4,330 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for VIDEX EC |
What excipients (inactive ingredients) are in VIDEX EC? | VIDEX EC excipients list |
DailyMed Link: | VIDEX EC at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for VIDEX EC
Paragraph IV (Patent) Challenges for VIDEX EC
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
VIDEX EC | Delayed-release Capsules | didanosine | 200 mg, 250 mg and 400 mg | 021183 | 1 | 2004-06-01 |
US Patents and Regulatory Information for VIDEX EC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bristol Myers Squibb | VIDEX EC | didanosine | CAPSULE, DELAYED REL PELLETS;ORAL | 021183-001 | Oct 31, 2000 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bristol Myers Squibb | VIDEX EC | didanosine | CAPSULE, DELAYED REL PELLETS;ORAL | 021183-004 | Oct 31, 2000 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bristol Myers Squibb | VIDEX EC | didanosine | CAPSULE, DELAYED REL PELLETS;ORAL | 021183-002 | Oct 31, 2000 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bristol Myers Squibb | VIDEX EC | didanosine | CAPSULE, DELAYED REL PELLETS;ORAL | 021183-003 | Oct 31, 2000 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for VIDEX EC
International Patents for VIDEX EC
See the table below for patents covering VIDEX EC around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | H0215523 | ⤷ Try a Trial | |
Ireland | 862265 | ⤷ Try a Trial | |
European Patent Office | 0472663 | ⤷ Try a Trial | |
Canada | 1269044 | INHIBITION DE L'INFECTIVITE IN VITRO ET DE L'EFFET CYTOPATHIQUE DU VIRUS HTLV-III/LAV PAR LA 2'3'-DIDEOXYINOSINE, LA 2'3'-DIDEOXYGUANOSINE OU LA 2'3'-DIDEOXYADENOSINE (INHIBITION OF IN VITRO INFECTIVITY AND CYTOPATHIC EFFECT OF HTLV-III/LAV BY 2'3'-DIDEOXYINOSINE, 2'3' - DIDEOXYGUANOSINE, OR 2'3' -DIDEOXYADENOSINE) | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 9014091 | ⤷ Try a Trial | |
Australia | 6196886 | ⤷ Try a Trial | |
European Patent Office | 0216510 | Inhibition de l'infectivité in vitro et de l'effet cytopathique du HTLV-III/LAV par la 2'3'-didéoxyinosine, la 2'3'-didéoxyguanosine ou par la 2'3'-didéoxyadénosine. (Inhibition of in vitro infectivity and cytopathic effect of HTLV-III/LAV by 2'3'-dideoxyinosine, 2'3'-dideoxyguanosine, or 2'3'-dideoxyadenosine.) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for VIDEX EC
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0216510 | SZ 54/1994 | Austria | ⤷ Try a Trial | PRODUCT NAME: 2',3'-DIDEOXYINOSIN |
0216510 | 94C0006 | Belgium | ⤷ Try a Trial | PRODUCT NAME: DIDANOSINE; NAT. REG.: 203 IS 225 F 3 19930331; FIRST REG.: FR 557 386-4 19920505 |
0285237 | 94C0006 | France | ⤷ Try a Trial | PRODUCT NAME: DIDANOSINE; NAT. REG.: 203 IS 225 F 3 19930331; FIRST REG.: FR 557 386-4 19920505 |
0216510 | SPC/GB94/005 | United Kingdom | ⤷ Try a Trial | SPC/GB94/005:, EXPIRES: 20070504 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |